Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients

References

• Feld R. Bloodstream infections in cancer patients with febrile neutropenia. Int J Antimicrob Agents. 2008;32(Suppl 1):S30–S33.
   PubMed Web of Science ®Google Scholar
• Montassier E, Batard E, Gastinne T, et al. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis. 2013;32:841–850.
   PubMed Web of Science ®Google Scholar
• Gudiol C, Garcia-Vidal C, Arnan M, et al. Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients . Bone Marrow Transplant. 2014;49:824–830.
   PubMed Web of Science ®Google Scholar
• Klastersky J, Ameye L, Maertens J, et al. Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents. 2007;30(Suppl 1):S51–S59.
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:427–431.
   PubMed Web of Science ®Google Scholar
• Kibbler CC, Prentice HG. Pathogen 'shift' in febrile neutropenia. Curr Opin Infect Dis. 1999;12:351–354.
   PubMed Web of Science ®Google Scholar
• Hämäläinen S, Kuittinen T, Matinlauri I, et al. Severe sepsis in autologous stem cell transplant recipients: microbiological aetiology, risk factors and outcome. Scand J Infect Dis. 2009;41:14–20.
   PubMed Web of Science ®Google Scholar
• Åttman E, Aittoniemi J, Sinisalo M, et al. Etiology, clinical course and outcome of healthcare-associated bloodstream infections in patients with hematological malignancies: a retrospective study of 350 patients in a Finnish tertiary care hospital. Leuk Lymphoma. 2015;56:3370–3377.
   PubMed Web of Science ®Google Scholar
• Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface. Bone Marrow Transplant. 2009;44:453–455.
   PubMed Web of Science ®Google Scholar
• Gafter-Gvili A, Fraser A, Paul M, et al. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database Syst Rev. 2012;1:CD004386.
   PubMedGoogle Scholar
• Chong Y, Yakushiji H, Ito Y, et al. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies. Int J Infect Dis. 2011;15:277–281.
   PubMed Web of Science ®Google Scholar
• Macesic N, Morrissey CO, Cheng AC, et al. Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period. Transpl Infect Dis. 2014;16:887–896.
   PubMed Web of Science ®Google Scholar
• Balletto E, Mikulska M. Bacterial infections in hematopoietic stem cell transplant recipients. Mediterr J Hematol Infect Dis. 2015;7:e2015045.
   PubMed Web of Science ®Google Scholar
• Chong Y, Shimoda S, Yakushiji H, et al. Clinical impact of fluoroquinolone-resistant Escherichia coli in the fecal flora of hematological patients with neutropenia and levofloxacin prophylaxis. PLoS One. 2014;9:e85210.
   PubMed Web of Science ®Google Scholar
• Kjellander C, Björkholm M, Cherif H, et al. Hematological: low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study. Eur J Haematol. 2012;88:422–430.
   PubMed Web of Science ®Google Scholar
• Hämäläinen S, Pentikäinen J, Reijula J, et al. Old enemies in new disguises: emergence of Enterococcus faecium as a significant clinical problem at an adult haematology ward. Infect Dis (Lond). 2017;49:628–631.
   PubMed Web of Science ®Google Scholar
• Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002; 34:730–751.
   PubMed Web of Science ®Google Scholar
• Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–1655.
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–810.
   PubMed Web of Science ®Google Scholar
• Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250–1256.
   PubMed Web of Science ®Google Scholar
• Jantunen E, Canals C, Rambaldi A, EBMT Lymphoma Working Party, et al. Autologous stemcell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: analysis based on data in the European Blood and Marrow Transplantation registry. Haematologica. 2008;93:1837–1842.
   PubMed Web of Science ®Google Scholar
• Aust C, Tolfvenstam T, Broliden K, et al. Bacteremia in Swedish hematological patients with febrile neutropenia: bacterial spectrum and antimicrobial resistance patterns. Scand J Infect Dis. 2013;45:285–291.
   PubMed Web of Science ®Google Scholar
• Sigurdardottir K, Digranes A, Harthug S, et al. A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility. Scand J Infect Dis. 2005;37:455–464.
   PubMed Web of Science ®Google Scholar
• Kolonen A, Sinisalo M, Huttunen R, et al. Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol - a prospective nationwide study. Infect Dis (Lond). 2017;49:799–808.
   PubMed Web of Science ®Google Scholar
• de Regt MJ, van der Wagen LE, Top J, et al. High acquisition and environmental contamination rates of CC17 ampicillin-resistant Enterococcus faecium in a Dutch hospital. J Antimicrob Chemother. 2008;62:1401–1406.
   PubMed Web of Science ®Google Scholar
• Craig M, Cumpston AD, Hobbs GR, et al. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit. Bone Marrow Transplant. 2007;39:477–482.
   PubMed Web of Science ®Google Scholar
• Weber DJ, Rutala WA. Understanding and preventing transmission of healthcare-associated pathogens due to the contaminated hospital environment. Infect Control Hosp Epidemiol. 2013;34:449–452.
   PubMed Web of Science ®Google Scholar
• Eleutherakis-Papaiakovou E, Kostis E, Migkou M, et al. Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial. Am J Hematol. 2010;85:863–867.
   PubMed Web of Science ®Google Scholar
• Garnica M, Nouér SA, Pellegrino FL, et al. Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance. BMC Infect Dis. 2013;13:356.
   PubMed Web of Science ®Google Scholar